Fig. 1From: Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-upFlow chart of the study cohort. Abbreviations: ER oestrogen receptor, HER2 human epidermal growth factor receptor 2, PR progesterone receptor, TILs tumour-infiltrating lymphocytes, TNBC triple-negative breast cancerBack to article page